Tauriga Sciences, Inc.
TAUG · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Market Cap | $22,073 | $2,631 | $11,666 | $1,985 |
| - Cash | $50 | $5 | $386 | $12 |
| + Debt | $569 | $658 | $214 | $255 |
| Enterprise Value | $22,592 | $3,284 | $11,494 | $2,227 |
| Revenue | $285 | $234 | $57 | $1 |
| % Growth | 21.7% | 310.2% | 4,709.3% | – |
| Gross Profit | $123 | $37 | $20 | $0 |
| % Margin | 43% | 15.9% | 35% | 39.8% |
| EBITDA | -$2,532 | -$2,130 | -$816 | -$1,972 |
| % Margin | -887.3% | -908.8% | -1,429% | -165,982.7% |
| Net Income | -$3,626 | -$3,033 | -$1,097 | -$36 |
| % Margin | -1,271% | -1,294.1% | -1,920.8% | -3,041% |
| EPS Diluted | -0.024 | -0.049 | -0.02 | -0.001 |
| % Growth | 49.8% | -143% | -3,233.3% | – |
| Operating Cash Flow | -$2,555 | -$1,511 | -$329 | $260 |
| Capital Expenditures | -$16 | -$3 | -$12 | -$3 |
| Free Cash Flow | -$2,571 | -$1,513 | -$341 | $256 |